AI-Supported Platform Innovation for Maternal Health

Bernard Olayo of the Center for Public Health and Development in Kenya will develop an AI-based platform to support product innovation for women's health, pilot testing it with Kenyan healthcare providers using heat-stable carbetocin, a drug for preventing postpartum hemorrhage. The platform will broadly serve providers as a resource for new product information, current clinical guidelines, and decision-making support. They will develop the platform through an initial focus on the drug carbetocin as a product with high potential for impact. They will build a library of reference materials for carbetocin, including guidelines contextualized for different healthcare settings; use the library to train a chatbot integrated into WhatsApp; and deploy the platform through relevant professional societies. They will evaluate the platform's impact based on data on providers' use of the chatbot, carbetocin use at Kenyan health facilities, and trends in maternal health outcomes at health facilities using the drug.